Skip to main content
The BMJ logoLink to The BMJ
letter
. 1992 Mar 14;304(6828):712–713. doi: 10.1136/bmj.304.6828.712-c

The cholesterol controversy.

T Winder
PMCID: PMC1881525  PMID: 1571655

Full text

PDF
712

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davey Smith G., Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs? BMJ. 1992 Feb 15;304(6824):431–434. doi: 10.1136/bmj.304.6824.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Tsevat J., Weinstein M. C., Williams L. W., Tosteson A. N., Goldman L. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation. 1991 Apr;83(4):1194–1201. doi: 10.1161/01.cir.83.4.1194. [DOI] [PubMed] [Google Scholar]
  3. Wysowski D. K., Gross T. P. Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs. Arch Intern Med. 1990 Oct;150(10):2169–2172. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES